Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effects of Phoniatric PREhabilitation in Head and Neck Cancer patients on Aspiration and Preservation of Swallowing (PREHAPS): study protocol of a monocentric prospective randomized interventional outcome-blinded trial.
Kuenzel J, Duerr S, Vester S, Zeman F, Huppertz G, Koller M, Pfleger G, Woertgen A, Salloum H, Klinkhammer-Schalke M, Pukrop T, Kummer P. Kuenzel J, et al. Among authors: koller m. Trials. 2024 Mar 22;25(1):211. doi: 10.1186/s13063-024-08010-2. Trials. 2024. PMID: 38519961 Free PMC article.
Treatment of sleep apnoea early after myocardial infarction with adaptive servo-ventilation: a proof-of-concept randomised controlled trial.
Arzt M, Fox H, Stadler S, Hetzenecker A, Oldenburg O, Hamer OW, Poschenrieder F, Wiest C, Tanacli R, Kelle S, Bruch L, Seidel M, Koller M, Zeman F, Buchner S; TEAM-ASV I Investigators. Arzt M, et al. Among authors: koller m. Eur Respir J. 2024 Sep 5;64(3):2302338. doi: 10.1183/13993003.02338-2023. Print 2024 Sep. Eur Respir J. 2024. PMID: 38991707 Clinical Trial.
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.
Corbacioglu S, Lode H, Ellinger S, Zeman F, Suttorp M, Escherich G, Bochennek K, Gruhn B, Lang P, Rohde M, Debatin KM, Steinbach D, Beilken A, Ladenstein R, Spachtholz R, Heiss P, Hellwig D, Tröger A, Koller M, Menhart K, Riemenschneider MJ, Zoubaa S, Kietz S, Jakob M, Sommer G, Heise T, Hundsdörfer P, Kühnle I, Dilloo D, Schönberger S, Schwabe G, von Luettichau I, Graf N, Schlegel PG, Frühwald M, Jorch N, Paulussen M, Schneider DT, Metzler M, Leipold A, Nathrath M, Imschweiler T, Christiansen H, Schmid I, Crazzolara R, Niktoreh N, Cario G, Faber J, Demmert M, Babor F, Fröhlich B, Bielack S, Bernig T, Greil J, Eggert A, Simon T, Foell J. Corbacioglu S, et al. Among authors: koller m. Lancet Oncol. 2024 Jul;25(7):922-932. doi: 10.1016/S1470-2045(24)00202-X. Lancet Oncol. 2024. PMID: 38936379 Free article. Clinical Trial.
Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs.
van der Weijst L, Machingura A, Alanya A, Lidington E, Velikova G, Flechtner HH, Schmidt H, Lehmann J, Ramage JK, Ringash J, Wac K, Oliver K, Taylor KJ, Wintner L, Senna LPC, Koller M, Husson O, Bultijnck R, Wilson R, Singer S, Bjelic-Radisic V, van der Graaf WTA, Pe M; EORTC Quality of Life Group. van der Weijst L, et al. Among authors: koller m. Eur J Cancer. 2024 Sep 18;212:114313. doi: 10.1016/j.ejca.2024.114313. Online ahead of print. Eur J Cancer. 2024. PMID: 39305741 Review.
A harmonized occupational biomonitoring approach.
Hopf NB, Rousselle C, Poddalgoda D, Lamkarkach F, Bessems J, Schmid K, Jones K, Takaki K, Casteleyn L, Zare Jeddi M, Bader M, Koller M, Browne P, FitzGerald R, Viegas S, Göen T, Santonen T, Väänänen V, Duca RC, Pasanen-Kase R. Hopf NB, et al. Among authors: koller m. Environ Int. 2024 Sep;191:108990. doi: 10.1016/j.envint.2024.108990. Epub 2024 Aug 31. Environ Int. 2024. PMID: 39244955 Free article. Review.
1,169 results